C12N 2800/30
Vector systems comprising sequences for excision in presence of a recombinase
Official title: Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
C12N2800/30 (Vector systems comprising sequences for excision in presence of a recombinase) appears on 711 US grants and 1,410 published applications in this corpus.
Search patents in C12N- Granted patents
- 711
- Published applications
- 1,410
- Assignees
- 572
- Inventors
- 2,189
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 17 | 0 |
| 1999 | 14 | 0 |
| 2000 | 27 | 0 |
| 2001 | 23 | 8 |
| 2002 | 27 | 102 |
| 2003 | 26 | 124 |
| 2004 | 27 | 86 |
| 2005 | 21 | 77 |
| 2006 | 26 | 113 |
| 2007 | 25 | 50 |
| 2008 | 20 | 54 |
| 2009 | 23 | 55 |
| 2010 | 30 | 70 |
| 2011 | 20 | 54 |
| 2012 | 29 | 30 |
| 2013 | 28 | 41 |
| 2014 | 30 | 46 |
| 2015 | 30 | 40 |
| 2016 | 29 | 35 |
| 2017 | 20 | 47 |
| 2018 | 25 | 36 |
| 2019 | 21 | 41 |
| 2020 | 25 | 54 |
| 2021 | 26 | 42 |
| 2022 | 27 | 52 |
| 2023 | 22 | 35 |
| 2024 | 26 | 45 |
| 2025 | 22 | 41 |
| 2026 | 14 | 32 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Efficient non-meiotic allele introgression in livestock1 Sep 2026US 12,721,326 B2Tog Technologies, LLC
- Neurodegenerative and amyotrophic model animal25 Aug 2026US 12,714,076 B2Tokyo Metropolitan Institute of Medical Science
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- Cell surface tag exchange (CSTE) system for tracing and manipulation of cells during recombinase mediated cassette exchange integration of nucleic acid sequences to engineered receiver cells28 Jul 2026US 12,692,511 B2Genovie AB
- SmartBac baculovirus expression system and application thereof9 Jun 2026US 12,649,931 B2Institute of Biophysics, Chinese Pie Academy of Sciences
- Circular single-stranded dna molecules for recombinase-based gene editing17 Sep 2026US 2026/0275344 A1Fc IP Holdings, LLC
- Compositions and methods for targetable genetic recombination in plants10 Sep 2026US 2026/0265768 A1
- Hla class ii deficient cells, hla class i deficient cells capable of expressing hla class ii proteins, and uses thereof3 Sep 2026US 2026/0256896 A1University of Washington through its Center for Commercialization
- Chinese hamster artificial chromosome vector or fragment thereof and mammalian-derived cell comprising the same27 Aug 2026US 2026/0250706 A1Trans Chromosomics, Inc.
- A method for detecting protein targets of an enzyme using a biotin ligase20 Aug 2026US 2026/0243776 A1Leibniz-Institut Fur Alternsforschung—Fritz-Lipmann-Institut E.V. (Fli)
Most cited
By later US patents
- CRISPR-Cas systems and methods for altering expression of gene products1,186US 8,697,359 B1Massachusetts Institute of Technology · 2014
- CRISPR-Cas systems and methods for altering expression of gene products483US 8,945,839 B2Massachusetts Institute of Technology · 2015
- CRISPR-Cas systems and methods for altering expression of gene products470US 8,771,945 B1Massachusetts Institute of Technology · 2014
- Production of antibodies using Cre-mediated site-specific recombination285US 6,130,364 AAbgenix, Inc. · 2000
- Transgenic bovine266US 5,741,957 APharming B.V. · 1998